Lyell Immunopharma Inc’s filing revealed that its Director Klausner Richard acquired Company’s shares for reported $94942.0 on Mar 14 ’25. In the deal valued at $0.60 per share,158,000 shares were bought. As a result of this transaction, Klausner Richard now holds 843,365 shares worth roughly $0.4 million.
Then, Newton Charles W. bought 200,000 shares, generating $111,620 in total proceeds. Upon buying the shares at $0.56, the Chief Financial Officer now owns 200,000 shares.
Before that, Seely Lynn bought 175,000 shares. Lyell Immunopharma Inc shares valued at $106,190 were divested by the President and CEO at a price of $0.61 per share. As a result of the transaction, Seely Lynn now holds 712,500 shares, worth roughly $0.34 million.
BofA Securities downgraded its Lyell Immunopharma Inc [LYEL] rating to an Underperform from a a Buy in a research note published on October 30, 2024; the price target was decreased to $1 from $6. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who decreased its forecast for the stock in late June from “a Buy” to “a Neutral”. JP Morgan also remained covering LYEL and has decreased its forecast on August 28, 2023 with a “Neutral” recommendation from previously “an Overweight” rating. Morgan Stanley revised its rating on November 14, 2022. It rated LYEL as “an Equal-weight” which previously was an “an Overweight”.
Price Performance Review of LYEL
On Tuesday, Lyell Immunopharma Inc [NASDAQ:LYEL] saw its stock fall -6.46% to $0.48. Over the last five days, the stock has lost -27.34%. Lyell Immunopharma Inc shares have fallen nearly -24.42% since the year began. Nevertheless, the stocks have fallen -78.11% over the past one year. While a 52-week high of $3.14 was reached on 03/07/25, a 52-week low of $0.51 was recorded on 03/18/25. SMA at 50 days reached $0.6220, while 200 days put it at $1.1821.
Levels Of Support And Resistance For LYEL Stock
The 24-hour chart illustrates a support level at 0.4588, which if violated will result in even more drops to 0.4339. On the upside, there is a resistance level at 0.5308. A further resistance level may holdings at 0.5779. The Relative Strength Index (RSI) on the 14-day chart is 30.36, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1262, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 99.10%. Stochastics %K at 2.73% indicates the stock is a buying.
How much short interest is there in Lyell Immunopharma Inc?
A steep rise in short interest was recorded in Lyell Immunopharma Inc stocks on 2025-02-28, dropping by -3.44 million shares to a total of 8.09 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 11.53 million shares. There was a decline of -42.51%, which implies that there is a negative sentiment for the stock.
